Gut-to-Brain α-Synuclein Transmission in Parkinson’s Disease: Evidence for Prion-like Mechanisms

por Chen, Merry, Mor, Danielle E.
Publicado 2023

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease

por Mor, Danielle E, Ischiropoulos, Harry
Publicado 2018

Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease

por Mor, Danielle E., Murphy, Coleen T.
Publicado 2020

High-throughput behavioral screen in C. elegans reveals Parkinson’s disease drug candidates

por Sohrabi, Salman, Mor, Danielle E., Kaletsky, Rachel, Keyes, William, Murphy, Coleen T.
Publicado 2021

Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson’s in vivo models

por Chen, Merry, Vincent, Julie, Ezeanii, Alexis, Wakade, Saurabh, Yerigenahally, Shobha, Mor, Danielle E
Publicado 2022

CXCL12-Mediated Guidance of Migrating Embryonic Stem Cell-Derived Neural Progenitors Transplanted into the Hippocampus

por Hartman, Nathaniel W., Carpentino, Joseph E., LaMonica, Kristi, Mor, Danielle E., Naegele, Janice R., Grabel, Laura
Publicado 2010

Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria

por Mor, Danielle E., Sohrabi, Salman, Kaletsky, Rachel, Keyes, William, Tartici, Alp, Kalia, Vrinda, Miller, Gary W., Murphy, Coleen T.
Publicado 2020

GAIT-GM integrative cross-omics analyses reveal cholinergic defects in a C. elegans model of Parkinson’s disease

por McIntyre, Lauren M., Huertas, Francisco, Morse, Alison M., Kaletsky, Rachel, Murphy, Coleen T., Kalia, Vrinda, Miller, Gary W., Moskalenko, Olexander, Conesa, Ana, Mor, Danielle E.
Publicado 2022

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration

por Mor, Danielle E., Tsika, Elpida, Mazzulli, Joseph R., Gould, Neal S., Kim, Hanna, Daniels, Malcolm J., Doshi, Shachee, Gupta, Preetika, Grossman, Jennifer L., Tan, Victor X., Kalb, Robert G., Caldwell, Kim A., Caldwell, Guy A., Wolfe, John H., Ischiropoulos, Harry
Publicado 2017